Was the Novanta (NOVT) CEO’s share sale part of a Rule 10b5-1 trading plan?

Yes. The filing states the sales were effected under a pre-established Rule 10b5-1 trading plan. This plan was adopted on September 11, 2025, through a trust for which the CEO’s spouse serves as trustee, indicating pre-planned, automatic transactions.

Novanta (NOVT) CEO sells 6,500 shares under pre-set 10b5-1 trading plan

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Novanta Inc. Chief Executive Officer Matthijs Glastra reported an open-market sale of 6,500 shares of common stock. The shares were sold at a weighted-average price of $130.05 per share on April 17, 2026, under a pre-established Rule 10b5-1 trading plan.

Following this sale, he directly owns 56,761 shares of Novanta common stock and has an additional 54,382 shares held indirectly through the Matthijs Glastra 2021 Irrevocable Trust. The transaction was executed in multiple trades between $130.00 and $130.28 per share.

Insider Trade Summary 10b5-1

Net Seller: 6,500 shares ($845,325)

Net Sell 2 txns

Insider Glastra Matthijs

Role Chief Executive Officer

Sold 6,500 shs ($845K)

Type	Security	Shares	Price	Value
Sale	Common Stock	6,500	$130.05	$845K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 56,761 shares (Direct, null); Common Stock — 54,382 shares (Indirect, Matthijs Glastra 2021 Irrevocable Trust)

Footnotes (1)

The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee. This transaction was executed in multiple trades ranging from $130.00 to $130.28. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Key Figures

Shares sold: 6,500 shares Weighted-average sale price: $130.05 per share Price range of trades: $130.00–$130.28 per share +3 more

6 metrics

Shares sold 6,500 shares Open-market sale on April 17, 2026

Weighted-average sale price $130.05 per share Common stock sale on April 17, 2026

Price range of trades $130.00–$130.28 per share Multiple executions for the same transaction date

Direct holdings after sale 56,761 shares Common stock directly owned after the reported sale

Indirect trust holdings 54,382 shares Held via Matthijs Glastra 2021 Irrevocable Trust

Reported net share activity -6,500 shares Net buy/sell direction for this Form 4

Key Terms

Rule 10b5-1 trading plan, weighted-average price, open-market sale, indirect ownership, +1 more

5 terms

Rule 10b5-1 trading plan regulatory

"The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan..."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted-average price financial

"The price reported above reflects the weighted-average price."

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

indirect ownership financial

""ownership_type": "indirect""

Irrevocable Trust financial

"nature_of_ownership": "Matthijs Glastra 2021 Irrevocable Trust""

Form 4 Insider Transactions: What Each Field Means →

04/21/2026 - 04:17 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Glastra Matthijs

(Last)

(First)

(Middle)

C/O NOVANTA INC.

125 MIDDLESEX TURNPIKE

(Street)

BEDFORD

MASSACHUSETTS

01730

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NOVANTA INC [ NOVT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/17/2026		S⁽¹⁾		6,500	D	$130.05⁽²⁾	56,761	D
Common Stock								54,382	I	Matthijs Glastra 2021 Irrevocable Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

2. This transaction was executed in multiple trades ranging from $130.00 to $130.28. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

Power of Attorney on file

	/s/ John Burke, Attorney-in-Fact	04/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Novanta (NOVT) CEO Matthijs Glastra report in this Form 4 filing?

He reported selling 6,500 shares of Novanta common stock in an open-market transaction. The sale occurred on April 17, 2026, under a pre-established Rule 10b5-1 trading plan, at a weighted-average price of $130.05 per share.

How many Novanta (NOVT) shares does the CEO hold after this transaction?

After the sale, Matthijs Glastra directly owns 56,761 Novanta common shares. In addition, 54,382 shares are held indirectly through the Matthijs Glastra 2021 Irrevocable Trust, reflecting both direct and trust-related holdings reported in the filing.

At what price did the Novanta (NOVT) CEO sell his shares?

The reported weighted-average sale price was $130.05 per share. The filing notes that the transaction was executed in multiple trades, with individual prices ranging from $130.00 to $130.28 per share on the transaction date.

How many Novanta (NOVT) shares did the CEO sell in this Form 4 event?

He sold 6,500 shares of Novanta common stock in this reported transaction. According to the summary data, this is the only sale reported in the filing, with no purchases or option exercises disclosed for the same date.

What additional details are provided about the Novanta (NOVT) trade execution?

The filing explains that the sale was executed in multiple trades between $130.00 and $130.28. The CEO undertakes to provide full trade details, including share amounts and specific prices, upon request from regulators, the issuer, or its security holders.